Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
McKinsey
AstraZeneca
Moodys
Medtronic

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NALOXONE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Naloxone

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000192 Neurobiology of Opioid Dependence: 1 - 1 Withdrawn National Institute on Drug Abuse (NIDA) Phase 2 1993-01-01 The purpose of this study is to evaluate the effects of lamotrigine on naloxone-precipitated opiate withdrawal.
NCT00000192 Neurobiology of Opioid Dependence: 1 - 1 Withdrawn Yale University Phase 2 1993-01-01 The purpose of this study is to evaluate the effects of lamotrigine on naloxone-precipitated opiate withdrawal.
NCT00000193 Neurobiology of Opioid Dependence: 2 - 2 Withdrawn National Institute on Drug Abuse (NIDA) Phase 2 1993-01-01 The purpose of this study is to evaluate the effects of gamma hydroxybutyric on naloxone-precipitated opiate withdrawal.
NCT00000193 Neurobiology of Opioid Dependence: 2 - 2 Withdrawn Yale University Phase 2 1993-01-01 The purpose of this study is to evaluate the effects of gamma hydroxybutyric on naloxone-precipitated opiate withdrawal.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Naloxone

Condition Name

Condition Name for Naloxone
Intervention Trials
Opioid-Related Disorders 37
Pain 25
Opioid Dependence 16
Heroin Dependence 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Naloxone
Intervention Trials
Opioid-Related Disorders 59
Constipation 17
Substance-Related Disorders 16
Drug Overdose 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Naloxone

Trials by Country

Trials by Country for Naloxone
Location Trials
United States 356
China 21
Canada 17
Norway 13
Finland 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Naloxone
Location Trials
New York 34
California 26
Maryland 24
Texas 16
Florida 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Naloxone

Clinical Trial Phase

Clinical Trial Phase for Naloxone
Clinical Trial Phase Trials
Phase 4 59
Phase 3 47
Phase 2/Phase 3 8
[disabled in preview] 50
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Naloxone
Clinical Trial Phase Trials
Completed 143
Recruiting 39
Not yet recruiting 33
[disabled in preview] 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Naloxone

Sponsor Name

Sponsor Name for Naloxone
Sponsor Trials
National Institute on Drug Abuse (NIDA) 49
Mundipharma Research GmbH & Co KG 12
Indivior Inc. 12
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Naloxone
Sponsor Trials
Other 219
Industry 95
NIH 58
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Boehringer Ingelheim
Express Scripts
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.